iPath Pure Beta Sugar ETN
SGAR
SGAR was delisted on the 11th of April, 2018.
1 hedge funds and large institutions have $31K invested in iPath Pure Beta Sugar ETN in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
49% less capital invested
Capital invested by funds: $61K → $31K (-$30K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$37.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $31K | -$37.2K | -1,662 | -56% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| – | -$3K | -167 | Closed |
|
SGAR Hedge Fund Activity: Q4 2015 in Review
1 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q4 2015, worth a combined $31K — down 49% from $61K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SGAR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $37.2K.
- 1 institutional investor held iPath Pure Beta Sugar ETN (SGAR) as of Q4 2015, down from 2 in Q3 2015.
- Funds reported $31K of iPath Pure Beta Sugar ETN stock for Q4 2015, down 49% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Sugar ETN positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest iPath Pure Beta Sugar ETN seller in Q4 2015 was UBS Group, an estimated $37.2K sold.
Based on aggregated 13F filings for Q4 2015.